Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69:7–34.

Article  PubMed  Google Scholar 

Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17–48.

Article  PubMed  Google Scholar 

Japanese Gastric Cancer Treatment Guidelines. 6th ed. Gastric Cancer. 2021;2023(26):1–25.

Google Scholar 

Ajani JA, Bentrem DJ, Besh S, D’Amico TA, Das P, Denlinger C, et al. Gastric cancer, version 2.2013: featured updates to the NCCN Guidelines. J Natl Compr Canc Netw. 2013;11:531–46.

Article  CAS  PubMed  Google Scholar 

Okines A, Verheij M, Allum W, Cunningham D, Cervantes A. Gastric cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21:v50–4.

Article  PubMed  Google Scholar 

Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007;357:1810–20.

Article  CAS  PubMed  Google Scholar 

United Nations (2019). World Population Prospects 2019. https://population.un.org/wpp/assets/Files/WPP2019_10KeyFindings.pdf

Statistical Handbook of Japan 2023. https://wwwstatgojp/english/data/handbook/indexhtml.

Miyatani K, Saito H, Shimizu S, Kono Y, Murakami Y, Shishido Y, et al. Late start and insufficient S-1 dose in adjuvant chemotherapy can lead to poor prognosis in stage II/III gastric cancer. Int J Clin Oncol. 2019;24:1190–6.

Article  PubMed  Google Scholar 

Kono Y, Matsunaga T, Makinoya M, Shimizu S, Shishido Y, Miyatani K, et al. Preoperative low skeletal muscle volume can result in insufficient administration of S-1 adjuvant chemotherapy in older patients with stage II/III gastric cancer. Surg Today. 2023. https://doi.org/10.1007/s00595-023-02737-2.

Article  PubMed  PubMed Central  Google Scholar 

Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12:489–95.

Article  PubMed  Google Scholar 

Argilés JM, Busquets S, Stemmler B, López-Soriano FJ. Cancer cachexia: understanding the molecular basis. Nat Rev Cancer. 2014;14:754–62.

Article  PubMed  Google Scholar 

Gong C, Wan Q, Zhao R, Zuo X, Chen Y, Li T. Cachexia index as a prognostic indicator in patients with gastric cancer: a retrospective study. Cancers (Basel). 2022;14:4400.

Article  CAS  PubMed  Google Scholar 

Matsunaga T, Satio H, Sakano Y, Makinoya M, Shimizu S, Shishido Y, et al. Prognostic significance of the cachexia index in patients with unresectable advanced gastric cancer receiving palliative chemotherapy: a retrospective single-center study. Surg Today. 2024;54:231–9.

Article  CAS  PubMed  Google Scholar 

Jafri SH, Previgliano C, Khandelwal K, Shi R. Cachexia index in advanced non-small-cell lung cancer patients. Clin Med Insights Oncol. 2015;9:87–93.

Article  PubMed  PubMed Central  Google Scholar 

Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011; 14:101–12.

Konishi H, Ichikawa D, Itoh H, Fukuda K, Kakihara N, Takemura M, et al. Surgery for gastric cancer patients of age 85 and older: multicenter survey. World J Gastroenterol. 2017;23:1215–23.

Article  PubMed  PubMed Central  Google Scholar 

Takeshita H, Ichikawa D, Komatsu S, Kubota T, Okamoto K, Shiozaki A, et al. Surgical outcomes of gastrectomy for elderly patients with gastric cancer. World J Surg. 2013;37:2891–8.

Article  PubMed  Google Scholar 

Mizutani T, Yamaguchi K, Mizusawa J, Ito S, Nishida Y, Yabusaki H, et al. A phase III trial to confirm modified S-1 adjuvant chemotherapy for pathological stage II/III vulnerable elderly gastric cancer patients who underwent gastric resection (JCOG1507, BIRDIE). Jpn J Clin Oncol. 2018;48:1101–4.

Article  PubMed  Google Scholar 

Nagashima F, Ohtsu A, Yoshida S, Ito K. Japanese nationwide post-marketing survey of S-1 in patients with advanced gastric cancer. Gastric Cancer. 2005;8:6–11.

Article  PubMed  Google Scholar 

Prado CM, Baracos VE, McCargar LJ, Mourtzakis M, Mulder KE, Reiman T, et al. Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity. Clin Cancer Res. 2007;13:3264–8.

Article  CAS  PubMed  Google Scholar 

McMillan DC. Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care. 2009;12:223–6.

Article  PubMed  Google Scholar 

Imamura H, Matsuyama J, Nishikawa K, Endo S, Kawase T, Kimura Y, et al. Effects of an oral elemental nutritional supplement in gastric cancer patients with adjuvant S-1 chemotherapy after gastrectomy: A multicenter, open-label, single-arm, prospective phase II study (OGSG1108). Ann Gastroenterol Surg. 2021;5:776–84.

Article  PubMed  PubMed Central  Google Scholar 

Okada KI, Kouda K, Kawai M, Hirono S, Miyazawa M, Kitahata Y, et al. Supervised exercise therapy and adjuvant chemotherapy for pancreatic cancer: a prospective, single-arm, phase II open-label, nonrandomized, historically controlled study. J Am Coll Surg. 2022;235:848–58.

Article  PubMed  Google Scholar